Medicis Pharmaceutical Corp Watch

from DEFA14A 79 pages Agreement and Plan of Merger Among Medicis Pharmaceutical Corporation, Valeant Pharmaceuticals International, Valeant Pharmaceuticals International, Inc. and Merlin Merger Sub, Inc. Dated as of September 2, 2012

from 8-K 79 pages Agreement and Plan of Merger Among Medicis Pharmaceutical Corporation, Valeant Pharmaceuticals International, Valeant Pharmaceuticals International, Inc. and Merlin Merger Sub, Inc. Dated as of September 2, 2012

from SC 13G/A ~5 pages Joint Filing Agreement

from SC 13G ~1 page Joint Filing Agreement

from 10-Q 128 pages Agreement and Plan of Merger by and Among Medicis Pharmaceutical Corporation (“Parent”), Donatello, Inc. (“Merger Sub”), Liposonix, Inc. (The “Company”), Rebecca Robertson, as the Equityholders’ Representative (The “Equityholders’ Representative”) and Wilfred Jaeger, as the Alternate Equityholders’ Representative (The “Alternate Equityholders’ Representative”) Dated as of June 16, 2008

from 425 >50 pages Plan of reorganization, merger, acquisition or similar

from 8-K >50 pages Plan of reorganization, merger, acquisition or similar

from 8-K >50 pages Plan of reorganization, merger, acquisition or similar

from 8-K >50 pages Agreement of Merger Among Medicis and Genderm

from SC 13D/A 1 page Plan of reorganization, merger, acquisition or similar